ImmuCell (ICCC) Stock Chart & Stock Price History $6.41 +0.12 (+1.91%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImmuCell Stock Price Performance The ImmuCell (ICCC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 49.71%, with a year-to-date return of 24.47%. In the past month, the stock has increased 22.33%, reflecting recent market activity. As of the latest close, ImmuCell traded at $6.29 with a market cap of $56.84 million and volume of 4,602 shares. Five years ago, the stock traded at $4.25, representing a 50.82% increase over that period. At the time, it had a market cap of $34.22 million and a volume of 42,100 shares. Receive ICCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.84%1 Month Performance+22.33%3 Month Performance+33.54%Year-To-Date Performance+24.47%1 Year Performance+49.71%5 Year Performance+50.82% ICCC Stock Chart for Thursday, June, 12, 2025 ICCC Chart by TradingView ImmuCell Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$6.26$6.29+0.48%$6.30$6.254,602 shs$56.84 million06/10/2025$6.42$6.26-2.49%$6.50$6.1418,034 shs$56.57 million06/09/2025$6.53$6.42-1.68%$6.64$6.418,843 shs$58.02 million06/06/2025$6.68$6.53-2.25%$6.72$6.503,526 shs$59.01 million06/05/2025$6.75$6.68-1.04%$6.83$6.6815,762 shs$60.37 million06/04/2025$6.87$6.75-1.75%$7.01$6.7010,272 shs$61 million06/03/2025$6.78$6.87+1.33%$7.00$6.7110,623 shs$62.08 million06/02/2025$6.34$6.78+6.94%$6.95$6.3952,480 shs$61.27 million05/30/2025$6.26$6.34+1.28%$6.57$6.318,824 shs$57.30 million05/29/2025$6.25$6.26+0.16%$6.35$6.0028,195 shs$56.57 million Get the Latest News and Ratings for ICCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$6.25$6.25$6.31$6.2313,885 shs$56.48 million05/27/2025$6.52$6.25-4.14%$6.72$6.1721,660 shs$56.48 million05/26/2025$6.52$6.52$6.65$5.9720,435 shs$58.92 million05/23/2025$6.18$6.52+5.50%$6.65$5.9720,435 shs$58.92 million05/22/2025$6.14$6.18+0.65%$6.84$6.1289,745 shs$55.85 million05/21/2025$5.54$6.14+10.83%$6.45$5.5467,319 shs$55.49 million05/20/2025$5.48$5.54+1.09%$5.58$5.4222,827 shs$50.07 million05/19/2025$5.27$5.48+3.98%$5.49$5.278,770 shs$49.52 million05/16/2025$5.30$5.27-0.57%$5.48$5.2132,156 shs$47.40 million05/15/2025$4.91$5.30+7.94%$5.55$5.1646,438 shs$47.67 million05/14/2025$4.97$4.91-1.21%$5.10$4.9115,285 shs$44.16 million05/13/2025$5.24$4.97-5.15%$5.28$4.7855,218 shs$44.70 million05/12/2025$5.07$5.24+3.35%$5.30$5.0326,191 shs$47.13 million Related Companies OCGN Stock Price Chart AMRN Stock Price Chart AARD Stock Price Chart MDWD Stock Price Chart TVGN Stock Price Chart ANNX Stock Price Chart FHTX Stock Price Chart SLRN Stock Price Chart DSGN Stock Price Chart URGN Stock Price Chart Receive ICCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ICCC) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmuCell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
